T., N. et al. 2026. ADVANCED NANOTHERAPEUTICS IN MULTIPLE SCLEROSIS TREATMENT: FROM BLOOD-BRAIN BARRIER CROSSING TO REMYELINATION ENHANCEMENT. International Journal of Applied Pharmaceutics. 18, 1 (Jan. 2026), 71–83. DOI:https://doi.org/10.22159/ijap.2026v18i1.56603.